Literature DB >> 35446142

Respiratory Influenza Virus Infection Causes Dynamic Tuft Cell and Innate Lymphoid Cell Changes in the Small Intestine.

Shanley N Roach1,2, Jessica K Fiege2,3, Frances K Shepherd2, Talia D Wiggen2, Ryan C Hunter2, Ryan A Langlois2,3.   

Abstract

Influenza A viruses (IAV) can cause severe disease and death in humans. IAV infection and the accompanying immune response can result in systemic inflammation, leading to intestinal damage and disruption of the intestinal microbiome. Here, we demonstrate that a specific subset of epithelial cells, tuft cells, increase across the small intestine during active respiratory IAV infection. Upon viral clearance, tuft cell numbers return to baseline levels. Intestinal tuft cell increases were not protective against disease, as animals with either increased tuft cells or a lack of tuft cells did not have any change in disease morbidity after infection. Respiratory IAV infection also caused transient increases in type 1 and 2 innate lymphoid cells (ILC1 and ILC2, respectively) in the small intestine. ILC2 increases were significantly blunted in the absence of tuft cells, whereas ILC1s were unaffected. Unlike the intestines, ILCs in the lungs were not altered in the absence of tuft cells. This work establishes that respiratory IAV infection causes dynamic changes to tuft cells and ILCs in the small intestines and that tuft cells are necessary for the infection-induced increase in small intestine ILC2s. These intestinal changes in tuft cell and ILC populations may represent unexplored mechanisms preventing systemic infection and/or contributing to severe disease in humans with preexisting conditions. IMPORTANCE Influenza A virus (IAV) is a respiratory infection in humans that can lead to a wide range of symptoms and disease severity. Respiratory infection can cause systemic inflammation and damage in the intestines. Few studies have explored how inflammation alters the intestinal environment. We found that active infection caused an increase in the epithelial population called tuft cells as well as type 1 and 2 innate lymphoid cells (ILCs) in the small intestine. In the absence of tuft cells, this increase in type 2 ILCs was seriously blunted, whereas type 1 ILCs still increased. These findings indicate that tuft cells are necessary for infection-induced changes in small intestine type 2 ILCs and implicate tuft cells as regulators of the intestinal environment in response to systemic inflammation.

Entities:  

Keywords:  influenza virus; innate lymphoid cells; tuft cells

Mesh:

Year:  2022        PMID: 35446142      PMCID: PMC9093116          DOI: 10.1128/jvi.00352-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  72 in total

Review 1.  Mammalian gut immunity.

Authors:  Benoit Chassaing; Manish Kumar; Mark T Baker; Vishal Singh; Matam Vijay-Kumar
Journal:  Biomed J       Date:  2014 Sep-Oct       Impact factor: 4.910

2.  DADA2: High-resolution sample inference from Illumina amplicon data.

Authors:  Benjamin J Callahan; Paul J McMurdie; Michael J Rosen; Andrew W Han; Amy Jo A Johnson; Susan P Holmes
Journal:  Nat Methods       Date:  2016-05-23       Impact factor: 28.547

3.  Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation.

Authors:  Jian Wang; Fengqi Li; Haiming Wei; Zhe-Xiong Lian; Rui Sun; Zhigang Tian
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

Review 4.  Human Influenza Virus Infections.

Authors:  Christin Peteranderl; Susanne Herold; Carole Schmoldt
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 5.  Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells.

Authors:  Tsuyoshi Kiniwa; Kazuyo Moro
Journal:  Int Immunol       Date:  2021-04-22       Impact factor: 4.823

6.  ILC1 Confer Early Host Protection at Initial Sites of Viral Infection.

Authors:  Orr-El Weizman; Nicholas M Adams; Iona S Schuster; Chirag Krishna; Yuri Pritykin; Colleen Lau; Mariapia A Degli-Esposti; Christina S Leslie; Joseph C Sun; Timothy E O'Sullivan
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

7.  Skn-1a/Pou2f3 is required for the generation of Trpm5-expressing microvillous cells in the mouse main olfactory epithelium.

Authors:  Tatsuya Yamaguchi; Junpei Yamashita; Makoto Ohmoto; Imad Aoudé; Tatsuya Ogura; Wangmei Luo; Alexander A Bachmanov; Weihong Lin; Ichiro Matsumoto; Junji Hirota
Journal:  BMC Neurosci       Date:  2014-01-16       Impact factor: 3.288

8.  MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.

Authors:  Christopher J Oliphant; You Yi Hwang; Jennifer A Walker; Maryam Salimi; See Heng Wong; James M Brewer; Alexandros Englezakis; Jillian L Barlow; Emily Hams; Seth T Scanlon; Graham S Ogg; Padraic G Fallon; Andrew N J McKenzie
Journal:  Immunity       Date:  2014-07-31       Impact factor: 31.745

9.  Characterisation of innate lymphoid cell populations at different sites in mice with defective T cell immunity.

Authors:  Emma E Dutton; Ana Camelo; Matthew Sleeman; Ronald Herbst; Gianluca Carlesso; Gabrielle T Belz; David R Withers
Journal:  Wellcome Open Res       Date:  2017-12-14

10.  Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity.

Authors:  Christoph S N Klose; David Artis
Journal:  Cell Res       Date:  2020-05-06       Impact factor: 25.617

View more
  1 in total

1.  Injury-induced pulmonary tuft cells are heterogenous, arise independent of key Type 2 cytokines, and are dispensable for dysplastic repair.

Authors:  Justinn Barr; Maria Elena Gentile; Sunyoung Lee; Maya E Kotas; Maria Fernanda de Mello Costa; Nicolas P Holcomb; Abigail Jaquish; Gargi Palashikar; Marcella Soewignjo; Margaret McDaniel; Ichiro Matsumoto; Robert Margolskee; Jakob Von Moltke; Noam A Cohen; Xin Sun; Andrew E Vaughan
Journal:  Elife       Date:  2022-09-08       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.